Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2030

Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.

Patents
905

Quick answer

905 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7786165

    Aminophenylpropanoic acid derivative

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7786137

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7786149

    Thiadiazoles as CXC- and CC- chemokine receptor ligands

    Pharmacopeia Drug Discovery, Inc. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7786107

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7786120

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7786096

    Inhibition of antigen presentation with poorly catabolized polymers

    HALOZYME, INC. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. EP 2222277

    PEGYLIERTE LIPOSOMALE FORMULIERUNGEN ZUR PHOTODYNAMISCHEN BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN

    CERAMOPTEC GMBH [DE] · Granted Wed Sep 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Aug 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7790738

    Methods of treating and preventing AIDS using of COX-2 inhibitors

    Lauras AS · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7790734

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7790728

    Pyrazine derivatives useful as adenosine receptor antagonists

    Laboratories Almirall, S.A. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7790735

    Methanocarba cycloalkyl nucleoside analogues

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7790039

    Tangential flow filtration devices and methods for stem cell enrichment

    Northwest Biotherapeutics, Inc. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7790186

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7790703

    Phosphonate compounds

    The Regents of the University of California · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7790433

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7790181

    Live attenuated viral vaccines for Eastern Equine Encephalitis virus

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7790159

    Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7790158

    Methods for epitope-specific and cytokine/anticytokine combination immunotherapies

    The Regents of the University of California · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7790764

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7790713

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7790473

    Biofunctionalized quantum dots for biological imaging

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7790182

    Protein vaccines against poxviruses

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7790835

    Method of preparing maleimide functionalized polymers

    Nektar Therapeutics · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7790766

    Pharmaceutical compositions of short-acting sedative hypnotic agent

    Theravance, Inc. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7790755

    Controlled release preparation

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7790736

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7790878

    RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7790860

    Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7790899

    Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms

    ACADIA Pharmaceuticals Inc. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. AU 2009200642

    Method using enoxaparin for reducing the risk of death in acutely ill medical patients

    AVENTIS PHARMA SA [FR] · Granted Thu Sep 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7795428

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7794730

    Polyvalent attenuated live vaccine for preventing and curing vibriosis of cultivated fish

    East China University of Science and Technology · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7795208

    Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7794717

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7794714

    Newcastle disease virus monoclonal antibodies

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7794726

    Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use

    The Boards of Regents of the University of Oklahoma · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7794734

    Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever

    The Board of Regents for Oklahoma State University · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7794998

    Primate T-lymphotropic viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7795209

    Anti-angiogenic methods and compositions

    Sangamo Biosciences, Inc. · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7795274

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7795259

    Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7795267

    Bicyclic piperazine compound having TGR23 antagonistic activity

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7795305

    CDDO-compounds and combination therapies thereof

    The Board of Regents of the University of Texas System · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7795495

    Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them

    The Regents of the University of California · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7794957

    Eukaryotic genes involved in adult lifespan regulation

    The Regents of the University of California · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7795295

    Small molecule inhibition of PDZ-domain interaction

    The Regents of the University of California · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7795300

    External preparation for skin

    KURARAY CO., LTD. · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7795302

    Use of compositions for treating rosacea

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2030?

905 published patents in our USPTO index have expiration dates falling in calendar year 2030.